New Findings Highlight Good Start Genetics, Inc.’ NGS Screening Capabilities In Ethnically Diverse Populations

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Good Start Genetics®, Inc., an innovative molecular genetic information company that has designed a proprietary technology platform to harness the power of next-generation DNA sequencing (NGS) to detect mutations that cause inherited genetics disorders, today announced that new clinical validation data for certain genetic carrier screening tests included in the GoodStart SelectTM menu, were presented at the American College of Medical Genetics and Genomics (ACMG) Annual Meeting in Nashville.

Help employers find you! Check out all the jobs and post your resume.